[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 13, Issue 3 (10-2011) ::
J Gorgan Univ Med Sci 2011, 13(3): 65-71 Back to browse issues page
Gene experison of cell proliferative marker Ki67 in breast cancer
Golmohammadi R (PhD) * 1, Pejhan A (PhD)2
1- Assistant Professor, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran , rahimgolmohammadi@yahoo.com
2- Assistant Professor, Department of Physiolog, Sabzevar University of Medical Sciences, Sabzevar, Iran
Abstract:   (57338 Views)
Background and Objective: Breast cancer is one of the most important malignant tumors world -wide and the second common cancer in the females. Breast cancer is associated with a number of environmental factors and genetic damages. Ki67 is a proto-oncogene which is activated in cell proliferation process. Ki67 is important in prognosis and response to chemotherapy. The aim of this study was to investigate the Ki67 gene expression in patients with breast cancer by immunohistochemistry method. Materials and Methods: This descriptive laboratory study was conducted on 80 breast cancer specimens from patients admitted to the hospitals in Sabzevar, Iran during 2005-09. Samples were fixed in formalin, the tissue processing was done and sections were stained by Hematoxilin and Eosin method. The malignancy was diagnosed by two pathologists blindly. Over expression of ki67 was determined with the immunohistochemistry method. Slides were scored into negative, weak, average and strong based on percentage of cells which were stained. The Data were analyzed by SPSS-11.5, Chi-Square and Fisher’s exact tests. Results: Ki67 proliferative marker was observed in 37 (46.3%) specimens with breast cancer. Sensivity of staining was one positive (+) in 15 cases, two positive (++) in 14 cases and three positive (+++) in 8 cases. There was a significant relationship between Ki67 gene expression and tumor type and tumor staging (P<0.05), but there was no significant relationship between Ki67 gene expression and tumor grade. Conclusion: It is concluded that, ki67 is expressed mostly in invasive and developed breast cancer.
Keywords: Breast cancer, ki67 expression, Immunohistochemistry
Full-Text [PDF 699 kb] [English Abstract]   (20024 Downloads)    
Type of Study: Original Articles | Subject: Pathology
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Golmohammadi R (PhD), Pejhan A (PhD). Gene experison of cell proliferative marker Ki67 in breast cancer. J Gorgan Univ Med Sci 2011; 13 (3) :65-71
URL: http://goums.ac.ir/journal/article-1-1167-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 3 (10-2011) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.07 seconds with 35 queries by YEKTAWEB 4652